Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Guangdong Marubi Biotechnology Co., Ltd. (603983.SS)
CNY28.86
-0.20 (-0.69%)
CN SHH Consumer Defensive Household & Personal Products
Address
South Tower of Poly Weizuo Building 510000
Guangzhou, CN
Guangzhou, CN
CEO
Huaiqing Sun
Website
marubi.cn
IPO
2019-07-25
ISIN CNE100003M51
Description
Established in 2002 and headquartered in Guangzhou, China, Guangdong Marubi Biotechnology Co., Ltd. specializes in a range of cosmetic products. While a key focus lies in providing eye care solutions across China, the company's activities span the entire process from scientific research and development, through design and production, to the ultimate sale of its beauty offerings. These products are formulated drawing upon expertise in both skin and biological sciences. Consumers can find their goods marketed under the brand names Marumi, Chunji, and Lianhuo.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
CNY28.86
-0.20 (-0.69%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
3M
Beta
0.20
Float Shares
77.00M
Free Float %
19.2%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.84% | +2.09% | +4.47% | -18.38% | -23.74% | -21.78% | -46.16% | -35.82% | -51.89% | -12.34% | -12.34% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
28.86
DCF (Unlevered)
13.16
-54.4%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
7.01
Safe zone
Piotroski F-Score
5 / 9
Average
MOAT Score
5 / 10
Developing
Composite Rating
B-
Overall Score
2 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
3 / 5
Medium
ROA Score
4 / 5
High
D/E Score
3 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Household & Personal Products: +3.3%+16.5% ★ Q1'26: +4.1% (vs Q1'25)
-
EPS growth Household & Personal Products: +8.8%-27.1% Q1'26: -26.5% (vs Q1'25)
-
FCF margin FCF growth · Household & Personal Products: +44.8%+6.7% Q1'26: -4.5% (vs Q1'25)
-
EBIT margin Household & Personal Products: +9.9%+8.6% Q1'26: +13.1% (vs Q1'25)
-
ROIC Household & Personal Products: +8.2%+12.5% ★ Q1'26: +16.4% (vs Q1'25)
-
Share dilution Household & Personal Products: +0.2%-0.2% ★ Q1'26: +1.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Household & Personal Products: -0.51×1.10× ★ Q1'26: 1.02× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 5 Rev. Ana. 3 EPS Ana. |
Dec 2027 8 Rev. Ana. 8 EPS Ana. |
Dec 2028 6 Rev. Ana. 6 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
1.80B
est: 1.88B (-4.2%)
|
1.74B
est: 1.85B (-5.6%)
|
1.79B
est: 1.74B (+2.7%)
|
1.73B
est: 1.87B (-7.2%)
|
2.23B
est: 2.52B (-11.6%)
|
2.97B
est: 2.93B (+1.5%)
|
3.46B
est: 3.68B (-6.1%)
|
3.90B
3.51B – 4.21B
+5.9% YoY
|
4.41B
3.75B – 4.99B
+13.0% YoY
|
4.86B
4.76B – 4.96B
+10.3% YoY
|
| EBITDA |
541.18M
est: 257.31M (+110.3%)
|
450.59M
est: 253.09M (+78.0%)
|
231.83M
est: 238.32M (-2.7%)
|
154.13M
est: 255.51M (-39.7%)
|
192.17M
est: 267.56M (-28.2%)
|
360.74M
est: 310.87M (+16.0%)
|
362.03M
est: 391.31M (-7.5%)
|
414.55M
373.31M – 446.83M
+5.9% YoY
|
468.25M
398.28M – 530.29M
+13.0% YoY
|
516.27M
505.49M – 527.05M
+10.3% YoY
|
| EBIT |
525.63M
est: 242.17M (+117.0%)
|
437.94M
est: 238.20M (+83.9%)
|
216.34M
est: 224.30M (-3.5%)
|
137.59M
est: 240.47M (-42.8%)
|
175.31M
est: 241.74M (-27.5%)
|
339.19M
est: 280.87M (+20.8%)
|
299.01M
est: 353.54M (-15.4%)
|
374.54M
337.29M – 403.71M
+5.9% YoY
|
423.06M
359.84M – 479.12M
+13.0% YoY
|
466.45M
456.71M – 476.19M
+10.3% YoY
|
| Net Income |
514.89M
est: 514.13M (+0.1%)
|
464.40M
est: 529.59M (-12.3%)
|
247.92M
est: 328.51M (-24.5%)
|
174.18M
est: 255.23M (-31.8%)
|
259.42M
est: 305.27M (-15.0%)
|
341.63M
est: 350.83M (-2.6%)
|
247.24M
est: 388.89M (-36.4%)
|
337.45M
308.91M – 348.85M
-13.2% YoY
|
426.99M
321.53M – 539.03M
+26.5% YoY
|
467.36M
366.52M – 554.85M
+9.5% YoY
|
| SGA |
631.08M
est: 964.46M (-34.6%)
|
642.71M
est: 948.63M (-32.2%)
|
841.66M
est: 893.28M (-5.8%)
|
957.43M
est: 957.70M (0.0%)
|
1.31B
est: 1.39B (-6.2%)
|
1.74B
est: 1.62B (+7.6%)
|
1.97B
est: 2.04B (-3.4%)
|
2.16B
1.94B – 2.33B
+5.9% YoY
|
2.44B
2.07B – 2.76B
+13.0% YoY
|
2.69B
2.63B – 2.75B
+10.3% YoY
|
| EPS |
1.37
est: 1.28 (+7.1%)
|
1.16
est: 1.32 (-12.0%)
|
0.62
est: 0.82 (-24.1%)
|
0.43
est: 0.63 (-30.6%)
|
0.65
est: 0.76 (-14.5%)
|
0.85
est: 0.88 (-3.7%)
|
0.62
est: 0.98 (-36.9%)
|
0.83
0.77 – 0.87
-15.1% YoY
|
1.00
0.80 – 1.34
+20.3% YoY
|
1.15
0.91 – 1.38
+14.5% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-11 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-08 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-07 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-06 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-30 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-29 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-28 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-27 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-24 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-23 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-22 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-21 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-20 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-17 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-16 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 2/5 | 1/5 | 2/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
216.32M
OE per share TTM
0.54
Owner's Yield
2.06%
Maintenance CapEx ratio
67.65%
Maint CapEx / Avg PPE
26.6%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 21 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Invesco FTSE All-World UCITS ETF FWRA.SW | 0.00% | 36.7K | 0.15% |
| 2 | Invesco FTSE All-World UCITS ETF FTWG.L | 0.00% | 36.6K | 0.15% |
| 3 | Vanguard FTSE Emerging Markets UCITS ETF (USD) Distributing VDEM.L | 0.00% | 43.7K | 0.17% |
| 4 | Vanguard FTSE Emerging Markets UCITS ETF (USD) Accumulating VFEA.L | 0.00% | 43.7K | 0.17% |
| 5 | Vanguard FTSE Emerging Markets All Cap Index ETF VEE.TO | 0.00% | 17.4K | 0.26% |
| 6 | Vanguard FTSE Emerging Markets Shares ETF VGE.AX | 0.00% | 7.7K | 0.48% |
| 7 | Vanguard FTSE Emerging Markets ETF VWO | 0.00% | 857.5K | 0.06% |
| 8 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 39.4K | 0.28% |
| 9 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 29.1K | 0.39% |
| 10 | Vanguard ESG International Stock ETF VSGX | 0.00% | 11.4K | 0.10% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
252.3K
Shares Outstanding
401.00M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Dan Huang | Head of Accounting Department & Accounting Supervisor | — | — |
| Di Cheng | Board Secretary | — | female |
| Huaiqing Sun | Chairman & Chief Executive Officer | — | male |
| Kaihui Wang | Chief Financial Officer & Director | — | male |
| Lingchun Zeng | Chief Marketing Officer & Director | — | male |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 603983.SS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
